Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer

Autor: Chick, R. Connor, Clifton, G. Travis, Hale, Diane F., Vreeland, Timothy J., Hickerson, Annelies T., Kemp Bohan, Phillip M., McCarthy, Patrick M., Litton, Jennifer K., Alatrash, Gheath, Murthy, Rashmi K., Qiao, Na, Philips, Anne, Lukas, Jason, Holmes, Jarrod P., Mittendorf, Elizabeth A., Peoples, George E.
Zdroj: In Clinical Immunology April 2021 225
Databáze: ScienceDirect
Externí odkaz: